Plasma cell myeloma type | Disease stage | Percentage of plasma cell bone marrow infiltratin | Kappa/lambda ratio | |
---|---|---|---|---|
IgA | lambda | IIIA | 66.1% | 0.0107 |
IgA | lambda | IIIB | 28.4% | 0.0514 |
IgA | lambda | IIIA | 63.3% | 0.1045 |
IgA | lambda | IIIA | 43.5% | 0.1747 |
IgA | kappa | IIA | 88.2% | 1.526 |
IgG | lambda | IIB | 78.1% | 0.00102 |
IgG | lambda | IIIB | 30.3% | 0.00703 |
IgG | lambda | IIIA | 59.8% | 0.00834 |
IgG | lambda | IIIA | 20.7% | 0.00127 |
IgG | lambda | IIB | 66.1% | 0.0161 |
IgG | lambda | IIB | 59.9% | 0.0115 |
IgG | lambda | IIIB | 32.2% | 0.0232 |
IgG | lambda | IIIA | 40.1% | 0.0418 |
IgG | lambda | IIIA | 20.2% | 0.0430 |
IgG | lambda | IIIB | 20.6% | 0.0509 |
IgG | lambda | IIIA | 12.3% | 0.0604 |
IgG | kappa | IIIA | 13.4% | 1.009 |
IgG | kappa | IA | 37.2% | 1.522 |
IgG | kappa | IA | 35.0% | 15.16 |
IgG | kappa | IIIb | 20.4% | 24.02 |
IgG | kappa | IIIA | 9.8% | 478.5 |
IgM | kappa | IIIA | 59.5% | 16.74 |
IgM | kappa | IIIA | 10.5% | 165.1 |
Bence-Jones | lambda | IIA | 6.1% | 0.0944 |
Bence-Jones | lambda | IIIA | 67.0% | 0.361 |
Bence-Jones | kappa | IIA | 76.8% | 52.66 |
Non-secretary | lambda | IIIB | 41.6% | 0.0672 |